Form D — DNA SEQ 2, INC.
0002115201-26-000001 · filed Mar 11, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(b)
- Reported offering amount
- $1,176,300
- Reported amount sold
- $1,176,300
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- DNA SEQ 2, INC.
- CIK
- 2115201
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 1255 E VISTA WAY #157
VISTA, California 92084 - Phone
- 585-987-2800
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Andrew Nappin · Executive OfficerVista, California Find on LinkedIn ↗
-
Stuart E. Siegel · DirectorVista, California Find on LinkedIn ↗
-
Janusz Maria Sowadski · DirectorVista, California Find on LinkedIn ↗
-
Eric Ladizinsky · DirectorVista, California Find on LinkedIn ↗
-
Thomas M. Wheeler · DirectorVista, California Find on LinkedIn ↗
-
Benjamin Anderson · DirectorVista, California Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗